Home  >  Products  >  TCF2 (transcription factor 2, hepatic; LF-B3; variant hepatic nuclear factor) Blocking Peptide (100ug)
TCF2 (transcription factor 2, hepatic; LF-B3; variant hepatic nuclear factor) Blocking Peptide (100ug)

TCF2 (transcription factor 2, hepatic; LF-B3; variant hepatic nuclear factor) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TCF2 antibody (Catalogue #: ARP32320_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP32320
Size: 100 ug
Weight: 45kDa
Gene: 6928
Format: Lyophilized powder
Target: TCF2 encodes transcription factor 2, a liver-specific factor of the homeobox-containing basic helix-turn-helix family. The TCF2 protein is believed to form heterodimers with another liver-specific member of this transcription factor family, TCF1; depending on the TCF2 isoform, the result may be to activate or inhibit transcription of target genes. Mutation of TCF2 that disrupts normal function has been identified as the cause of MODY5 (Maturity-Onset of Diabetes, Type 5).
See Full Product Listings >